Literature DB >> 29760271

Joey Ton1, Jamil Ramji1, G Michael Allan2.   

Abstract

Year:  2018        PMID： 29760271      PMCID： PMC5951666     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  14 in total

Review 1.  The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.

Authors:  C Ballard; J Waite
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

2.  The efficacy and safety of atypical antipsychotics for the treatment of dementia: a meta-analysis of randomized placebo-controlled trials.

Authors:  Hui Ma; Yinglin Huang; Zhengtu Cong; Yuan Wang; Wenhai Jiang; Shuhe Gao; Gang Zhu
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 3.  Quetiapine for the treatment of behavioural and psychological symptoms of dementia (BPSD): a meta-analysis of randomised placebo-controlled trials.

Authors:  Gary Cheung; Janli Stapelberg
Journal:  N Z Med J       Date:  2011-06-10

4.  Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

Authors:  Lon S Schneider; Karen Dagerman; Philip S Insel
Journal:  Am J Geriatr Psychiatry       Date:  2006-03       Impact factor: 4.105

Review 5.  Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline.

Authors:  Lise M Bjerre; Barbara Farrell; Matthew Hogel; Lyla Graham; Geneviève Lemay; Lisa McCarthy; Lalitha Raman-Wilms; Carlos Rojas-Fernandez; Samir Sinha; Wade Thompson; Vivian Welch; Andrew Wiens
Journal:  Can Fam Physician       Date:  2018-01       Impact factor: 3.275

6.  Meta-analysis of the effectiveness of atypical antipsychotics for the treatment of behavioural problems in persons with dementia.

Authors:  Craig A Yury; Jane E Fisher
Journal:  Psychother Psychosom       Date:  2007       Impact factor: 17.659

Review 7.  Haloperidol for agitation in dementia.

Authors:  E Lonergan; J Luxenberg; J Colford
Journal:  Cochrane Database Syst Rev       Date:  2002

8.  Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial.

Authors:  Paul B Rosenberg; Lea T Drye; Anton P Porsteinsson; Bruce G Pollock; D P Devanand; Constantine Frangakis; Zahinoor Ismail; Christopher Marano; Curtis L Meinert; Jacobo E Mintzer; Cynthia A Munro; Gregory Pelton; Peter V Rabins; Lon S Schneider; David M Shade; Daniel Weintraub; Jeffery Newell; Jerome Yesavage; Constantine G Lyketsos
Journal:  Int Psychogeriatr       Date:  2015-08-25       Impact factor: 3.878

Review 9.  Valproate preparations for agitation in dementia.

Authors:  Edmund Lonergan; Jay Luxenberg
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

10.  Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial.

Authors:  Bettina S Husebo; Clive Ballard; Reidun Sandvik; Odd Bjarte Nilsen; Dag Aarsland
Journal:  BMJ       Date:  2011-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.